Faculty & Staff

Richard A. Miller, MD, PhD

Glenn Center Director
Director, Core Facility for Slow-Aging Mice
Professor of Pathology

Room 3001 BSRB
109 Zina Pitcher Place
Ann Arbor, MI 48109-2200

Telephone: 734 936 2122
E-mail: millerr@umich.edu
Website: Miller Lab

Dr. Miller's laboratory uses mouse models and cell lines to study how genes, drugs, diets, and evolutionary processes can slow the rate of aging and prevent multiple forms of late life disease.

Ao-Lin A Hsu, PhD

Glenn Center
Model Systems Unit
Associate Professor of Internal Medicine and Molecular & Integrative Physiology

Room 2027 BSRB
109 Zina Pitcher Place
Ann Arbor, MI 48109-2200

Telephone: 734 615 2774
E-mail: aolinhsu@umich.edu
Website: http://medicine.umich.edu/dept/dgpm/ao-lin-hsu-phd

Dr. Hsu's laboratory uses the nematode C. elegans as a model organism to study the genetic, pharmacological, and dietary factors that influence the rate of aging and the onset of various age-related diseases.

David Lombard, MD, PhD

109 Zina Pitcher Place
Ann Arbor MI 48109
(734) 615-0498

Dr. Lombard's laboratory focuses on sirtuin proteins and their relationships with human disease, particularly cancer.

Scott Pletcher, PhD

Glenn Center Associate Director
Director, Model Systems Unit
Professor of Molecular and Integrative Physiology

Room 3021 BSRB
109 Zina Pitcher Place
Ann Arbor, MI 48109-2200

Telephone: 734 647-9383
E-mail: spletch@umich.edu
Website: Pletcher Lab

Dr. Pletcher's laboratory seeks to identify and investigate genetic mechanisms that are likely to be important for aging and age-related disease in humans by focusing on equivalent, conserved processes in the fruit fly, Drosophila melanogaster.

Zaneta Nikolovska-Coleska, PhD

Assistant Professor of Pathology
Director, MCP Graduate Program
4510E MSRB I
1150 West Medical Center Drive
Ann Arbor, MI 48109
Phone: (734) 615-3860
E-mail: zanetan@med.umich.edu

Dr. Nikolovska-Coleska's laboratory is primarily focused towards chemical genomics, discovery and application of active chemical compounds for the interrogation of biological systems and improvement of human health. For this purpose her group is applying different approaches including high throughput and virtual screening, structure-based design, chemical synthesis, biochemistry and genetics, with overall goals to understand the fundamental biology and produce molecules that might be therapeutically informative. Dr. Nikolovska-Coleska's research is particularly focused on understanding the protein-protein interactions (PPIs) involved in controlling the programmed cell death and regulating epigenetic mechanisms.